QQ客服 官方微博 反馈留言

	KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease
	Yi, Mengni[1]; Yu, Panpan[2,3]; Lu, Qin[1]; Geller, Herbert M.[4]; Yu, Zhihua[1]; Chen, Hongzhuan[1]
	2016
卷号	76期号:[db:dc_citation_issue]页码:21
DOI	[db:dc_identifier_doi]
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3360619
专题	暨南大学
作者单位	1.[1]Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Pharmacol, 280 South Chongqing Rd, Shanghai 200025, Peoples R China 2.[2]Jinan Univ, Guangdong Hongkong Macau Inst CNS Regenerat, Guangzhou 510632, Guangdong, Peoples R China 3.[3]Jinan Univ, Minist Educ, Joint Int Res Lab CNS Regenerat, Guangzhou 510632, Guangdong, Peoples R China 4.[4]NHLBI, Dev Neurobiol Sect, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA
推荐引用方式 GB/T 7714	Yi, Mengni[1],Yu, Panpan[2,3],Lu, Qin[1],et al. KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease[J],2016,76([db:dc_citation_issue]):21.
APA	Yi, Mengni[1],Yu, Panpan[2,3],Lu, Qin[1],Geller, Herbert M.[4],Yu, Zhihua[1],&Chen, Hongzhuan[1].(2016).KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease.,76([db:dc_citation_issue]),21.
MLA	Yi, Mengni[1],et al."KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease".76.[db:dc_citation_issue](2016):21.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。